Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bussel

Showing results (441-450 of 487) with videos related to

Pageof 49
Sort By:
Lancet (London, England)|April 23, 2016
Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled studyMichael D Tarantino, James B Bussel, Victor S Blanchette, et al.
Platelets|December 8, 2017
Effect of thrombopoietin receptor agonists on markers of coagulation and P-selectin in patients with immune thrombocytopeniaLamya Garabet, Waleed Ghanima, Christine Monceyron Jonassen, et al.
Health and Quality of Life Outcomes|February 12, 2008
Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspectiveSusan D Mathias, Sue K Gao, Kimberly L Miller, et al.
Blood|March 11, 2011
Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopeniaSarah J Barsam, Bethan Psaila, Marc Forestier, et al.
Blood|October 17, 2014
IRAK-4 and MyD88 deficiencies impair IgM responses against T-independent bacterial antigensPaul J Maglione, Noa Simchoni, Samuel Black, et al.
Lancet (London, England)|October 1, 2023
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trialCatherine M Broome, Vickie McDonald, Yoshitaka Miyakawa, et al.
Science Translational Medicine|September 14, 2018
Thrombopoietin receptor-independent stimulation of hematopoietic stem cells by eltrombopagYun-Ruei Kao, Jiahao Chen, Swathi-Rao Narayanagari, et al.
British Journal of Haematology|June 6, 2020
Fatigue in children and adolescents with immune thrombocytopeniaRachael F Grace, Robert J Klaassen, Kristin A Shimano, et al.
The Lancet. Haematology|April 2, 2025
Rising to the challenge: an international Delphi consensus study on fetal and neonatal alloimmune thrombocytopeniaRomy Pothof, Elske M van den Akker-van Marle, Thijs W de Vos, et al.
Blood|July 31, 2015
Effects of eltrombopag on platelet count and platelet activation in Wiskott-Aldrich syndrome/X-linked thrombocytopeniaAnja J Gerrits, Emily A Leven, Andrew L Frelinger, et al.
Pageof 49

Showing results (441-450 of 487) with videos related to

Sort By:
Pageof 49
Lancet (London, England)|April 23, 2016
Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled studyMichael D Tarantino, James B Bussel, Victor S Blanchette, et al.
Platelets|December 8, 2017
Effect of thrombopoietin receptor agonists on markers of coagulation and P-selectin in patients with immune thrombocytopeniaLamya Garabet, Waleed Ghanima, Christine Monceyron Jonassen, et al.
Health and Quality of Life Outcomes|February 12, 2008
Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspectiveSusan D Mathias, Sue K Gao, Kimberly L Miller, et al.
Blood|March 11, 2011
Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopeniaSarah J Barsam, Bethan Psaila, Marc Forestier, et al.
Blood|October 17, 2014
IRAK-4 and MyD88 deficiencies impair IgM responses against T-independent bacterial antigensPaul J Maglione, Noa Simchoni, Samuel Black, et al.
Lancet (London, England)|October 1, 2023
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trialCatherine M Broome, Vickie McDonald, Yoshitaka Miyakawa, et al.
Science Translational Medicine|September 14, 2018
Thrombopoietin receptor-independent stimulation of hematopoietic stem cells by eltrombopagYun-Ruei Kao, Jiahao Chen, Swathi-Rao Narayanagari, et al.
British Journal of Haematology|June 6, 2020
Fatigue in children and adolescents with immune thrombocytopeniaRachael F Grace, Robert J Klaassen, Kristin A Shimano, et al.
The Lancet. Haematology|April 2, 2025
Rising to the challenge: an international Delphi consensus study on fetal and neonatal alloimmune thrombocytopeniaRomy Pothof, Elske M van den Akker-van Marle, Thijs W de Vos, et al.
Blood|July 31, 2015
Effects of eltrombopag on platelet count and platelet activation in Wiskott-Aldrich syndrome/X-linked thrombocytopeniaAnja J Gerrits, Emily A Leven, Andrew L Frelinger, et al.
Pageof 49